Yongin-si, South Korea

Joon Woo Kim

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Axceso Biopharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joon Woo Kim. Retrieved from https://idiyas.com/inventor/joon-woo-kim-66ee6jf0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Joon Woo Kim in Cancer Treatment

Introduction

Joon Woo Kim is an accomplished inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. His innovative work has led to the creation of a unique compound that holds promise for cancer therapy.

Latest Patents

Joon Woo Kim holds a patent for a pyrimido pyrimidinone compound and a pharmaceutical composition comprising the same. This patent describes a compound that effectively inhibits PD-L1 expression, which is crucial in cancer progression. The pharmaceutical composition containing this compound serves as an active ingredient and can be utilized for the treatment or prevention of cancer.

Career Highlights

Currently, Joon Woo Kim is associated with Axceso Biopharma Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Some of his notable coworkers include Young Jun Park and Sung Jun Park, who contribute to the collaborative efforts within the company. Their combined expertise enhances the research environment and fosters innovation in pharmaceutical development.

Conclusion

Joon Woo Kim's contributions to cancer treatment through his patented innovations highlight the importance of research in pharmaceuticals. His work exemplifies the potential of targeted therapies in improving health outcomes for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…